Ningyu Wang
Union Hospital(CN)University of Electronic Science and Technology of China(CN)National Taiwan University(TW)Henan University of Science and Technology(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Sichuan Cancer Hospital(CN)Jiangsu Province Hospital(CN)Huazhong University of Science and Technology(CN)Southwest Jiaotong University(CN)Nanjing Medical University(CN)National Taipei University(TW)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Ubiquitin and proteasome pathways, Cancer therapeutics and mechanisms, Hepatitis C virus research
Most-Cited Works
- → Correction: Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer(2016)715 cited
- → The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model(2014)131 cited
- → Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2(2021)115 cited
- → Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis(2017)89 cited
- → Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis(2014)72 cited
- → Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma(2016)71 cited